Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | PLSE |
---|---|---|
09:32 ET | 550 | 17.32 |
09:34 ET | 500 | 16.7401 |
09:36 ET | 100 | 17.17 |
09:41 ET | 100 | 16.95 |
09:43 ET | 1000 | 17.13 |
09:54 ET | 100 | 17.13 |
09:59 ET | 100 | 17.28 |
10:03 ET | 104 | 17.16 |
10:10 ET | 700 | 16.9 |
10:12 ET | 108 | 16.792 |
10:14 ET | 659 | 16.78 |
10:15 ET | 100 | 16.91 |
10:19 ET | 105 | 17.01 |
10:24 ET | 500 | 16.9 |
10:28 ET | 1381 | 16.82 |
10:30 ET | 3600 | 16.89 |
10:32 ET | 103 | 16.88 |
10:33 ET | 150 | 16.795 |
10:37 ET | 100 | 16.8 |
10:42 ET | 2200 | 17 |
10:57 ET | 492 | 17 |
11:08 ET | 100 | 16.965 |
11:18 ET | 732 | 17.015 |
11:22 ET | 100 | 17.015 |
11:27 ET | 170 | 17.2318 |
11:36 ET | 900 | 17.2 |
11:44 ET | 100 | 17.24 |
11:49 ET | 227 | 17.355 |
11:54 ET | 500 | 17.36 |
11:58 ET | 5000 | 17.2442 |
12:03 ET | 715 | 17.24 |
12:05 ET | 100 | 17.18 |
12:12 ET | 2205 | 17.23 |
12:16 ET | 3000 | 17.0483 |
12:23 ET | 662 | 17.1869 |
12:25 ET | 143 | 17.3703 |
12:30 ET | 144 | 17.215 |
12:39 ET | 200 | 17.19 |
12:41 ET | 195 | 17.16 |
12:45 ET | 100 | 16.955 |
12:52 ET | 100 | 17.08 |
01:06 ET | 100 | 17.01 |
01:15 ET | 100 | 16.96 |
01:17 ET | 100 | 16.93 |
01:21 ET | 550 | 16.9 |
01:30 ET | 100 | 16.8 |
01:32 ET | 100 | 16.86 |
01:37 ET | 100 | 16.885 |
01:42 ET | 1605 | 16.805 |
01:44 ET | 1100 | 16.87 |
01:50 ET | 100 | 16.85 |
01:51 ET | 300 | 16.96 |
02:00 ET | 100 | 16.85 |
02:02 ET | 2071 | 16.85 |
02:04 ET | 100 | 16.8 |
02:06 ET | 100 | 16.8 |
02:08 ET | 200 | 16.8 |
02:09 ET | 100 | 16.8 |
02:11 ET | 100 | 16.82 |
02:13 ET | 600 | 16.8 |
02:15 ET | 100 | 16.8 |
02:18 ET | 100 | 16.8 |
02:20 ET | 200 | 16.8 |
02:22 ET | 100 | 16.8 |
02:24 ET | 300 | 16.825 |
02:26 ET | 400 | 16.8 |
02:27 ET | 1326 | 16.92 |
02:29 ET | 1000 | 17.015 |
02:33 ET | 100 | 16.92 |
02:38 ET | 100 | 16.82 |
02:40 ET | 100 | 16.82 |
02:42 ET | 200 | 16.8 |
02:44 ET | 100 | 16.8 |
02:45 ET | 200 | 16.8 |
02:47 ET | 266 | 16.8939 |
02:49 ET | 200 | 16.8 |
02:51 ET | 100 | 16.8 |
02:54 ET | 100 | 16.8 |
02:56 ET | 200 | 16.8 |
02:58 ET | 200 | 16.8 |
03:00 ET | 100 | 16.8 |
03:02 ET | 200 | 16.8 |
03:03 ET | 100 | 16.8 |
03:05 ET | 200 | 16.8 |
03:07 ET | 200 | 16.91 |
03:09 ET | 300 | 16.885 |
03:12 ET | 200 | 16.87 |
03:16 ET | 1207 | 16.83 |
03:18 ET | 673 | 16.8 |
03:20 ET | 659 | 16.8 |
03:21 ET | 200 | 16.775 |
03:23 ET | 3310 | 16.67 |
03:25 ET | 300 | 16.775 |
03:27 ET | 462 | 16.775 |
03:30 ET | 200 | 16.775 |
03:32 ET | 200 | 16.775 |
03:34 ET | 1250 | 16.79 |
03:36 ET | 965 | 16.8 |
03:38 ET | 200 | 16.8 |
03:39 ET | 400 | 16.8 |
03:41 ET | 200 | 16.8 |
03:43 ET | 1604 | 16.89 |
03:50 ET | 100 | 16.82 |
03:52 ET | 300 | 16.82 |
03:54 ET | 500 | 16.85 |
03:56 ET | 1300 | 16.9343 |
03:57 ET | 1559 | 16.85 |
03:59 ET | 22255 | 16.89 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Pulse Biosciences Inc | 1.0B | -21.3x | --- |
Atlantic International Corp | 292.4M | -0.7x | --- |
Nano-X Imaging Ltd | 346.9M | -6.1x | --- |
Simulations Plus Inc | 609.3M | 65.5x | +3.18% |
IRadimed Corp | 625.6M | 33.8x | +21.02% |
Clearpoint Neuro Inc | 311.0M | -15.7x | --- |
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers. The Company’s Nano-pulse Stimulation (NPS) technology is an energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. The Company has designed a variety of applicators, or end-effectors, to explore the potential use of the CellFX platform to treat disorders in other medical specialties, such as cardiology, gastroenterology, gynecology, and ear, nose, and throat.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.0B |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 61.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.75 |
EPS | $-0.79 |
Book Value | $0.80 |
P/E Ratio | -21.3x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.